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Abstract
Introduction: Giant condyloma acuminatum, also called a Buschke-Löwenstein tumor, first described in 1925, is a
slow-growing, locally aggressive, destructive tumor of the ano-genital region. Scrotal tumors are rare. Reports on
giant condyloma acuminatum lesions in patients with HIV and AIDS are surprisingly even rarer.
Case presentation: In this report, we present the case of a 42-year-old African man with AIDS who was
undergoing anti-retroviral therapy. He was found to have a giant condyloma acuminatum of the scrotum. Wide
surgical excision and scrotal reconstruction with a pedicled anterolateral thigh flap was performed, significantly
improving his quality of life.
Conclusion: Decision making regarding the goals of surgical intervention in the terminally ill is a complex process.
The options include conservative medical palliation or palliative excision versus a curative excision that has the
potential for significant morbidity. Wide surgical excision with local flap reconstruction significantly improved the
quality of life of the patient described herein. The challenges presented by emerging or unusual presentations of
surgical pathology secondary to HIV and AIDS in patients who are on anti-retroviral therapy provide an opportunity
for research and the establishment of guidelines for the use of adjuvant chemotherapy in these patients.
Introduction
Giant condyloma acuminatum, also known as Buschke-
Löwenstein tumor, was first described by Buschke and
Löwenstein in 1925. This slow-growing, locally destruc-
tive tumor of the ano-genital region is thought to be
induced by human papillomavirus (HPV), most com-
monly HPV types 6 and 11 and occasionally types 16
and 18. It is associated with extensive local infiltration
and a high propensity to recur. Most authors consider it
to be a verrucous carcinoma, a variant of squamous cell
carcinoma that seldom metastasizes [1,2]. Histological
examination, however, may reveal pockets of squamous
cell carcinoma, a risk factor for metastasis. Giant condy-
loma acuminatum most often affects the glans penis,
but has also been reported in the scrotum, vulva, the
peri-anal region, ano-rectum and the bladder [3].
Scrotal giant condyloma acuminatum tumors are rare.
While ano-genital condylomata acuminatum or warts
are common lesions in patients with HIV, giant
condyloma acuminatum and Buschke-Löwenstein
tumors in patients with HIV are very rare [4,5].
In this report, we describe the case of a patient with
AIDS undergoing anti-retroviral (ARV) therapy who
presented to our hospital with a giant condyloma acu-
minatum lesion of the scrotum, and we explore the
therapeutic difficulties posed by his care.
Case presentation
A 42-year-old African man was referred to our institu-
tion from another country with a large scrotal tumor
first noted five years prior to his presentation to our
institution. The mass had grown slowly over the years,
with ulceration associated with foul-smelling discharge
noted with time, along with seepage of urine from mul-
tiple fistuli in the growing scrotal mass (Figure 1). He
had been diagnosed with HIV, and ARV therapy had
been started two years prior to the development of the
scrotal mass. He also had the wasting syndrome, an
AIDS-defining diagnosis. He had been unable to walk
for three years prior to his visit to our institution. He
had been married, but was separated from his wife upon
developing the scrotal tumor.
* Correspondence: nthumba@gmail.com
Plastic, Reconstructive and Hand Surgery Unit, AIC Kijabe Hospital, Kijabe
00220, Kenya
Nthumba et al. Journal of Medical Case Reports 2011, 5:272
http://www.jmedicalcasereports.com/content/5/1/272 JOURNAL OF MEDICAL
CASE REPORTS
© 2011 Nthumba et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.The patient’s physical examination revealed that he
was emaciated. He had a large scrotal mass that
extended laterally into both thighs, superiorly into the
supra-pubic region and posteriorly to the anal verge. His
hips had a fixed flexion and abduction deformity.
His hemoglobin was 7.4 g/dL, and his CD4 lympho-
cyte count was 150 cells/mm
3. During surgery, the
tumor was found to have extended laterally into the
adductor musculature bi-laterally, requiring their inclu-
sion in the excision. The deep margins included the rec-
tus muscle fascia, pubis, pelvic diaphragm, and rectum
(Figure 2). A small part of the bulbous urethra was
excised with the tumor. The excised tumor weighed
1800 g and was reported on the basis of a histological
examination to be a giant condyloma acuminatum.
A pedicled left anterolateral thigh flap was used to
create a neo-scrotum as well as to cover the resulting
thigh defects (Figure 3). Negative pressure therapy was
used to exclude the surgical wounds from fecal matter
as well as to assist in draining the extensive surgical
field. The patient recovered and was discharged to
home with a urinary (urethral) catheter.
One month after discharge from the hospital, his
wounds were healed, except for a tiny wound in the
suture line of his neo-scrotum. His catheter accidentally
fell off, and he was noted to be leaking urine through the
wound previously noted. A supra-pubic cystostomy was
performed and a catheter was placed, and the perineal
urine leak was noted to have stopped a few weeks later.
Six months post-operatively, some tumor recurrence was
noted and discussions of chemotherapy were held but
were not implemented because of the potentially com-
plex interaction between the chemotherapy, ARVs, and
the patient’s precarious physical status.
Discussion
Giant condyloma acuminatum generally occurs in
adults, but has also been reported in children [6]. Poor
penile hygiene is a known predisposing factor, while
chronic inflammation (peri-anal fistuli), immunosup-
pression (HIV or therapy), diabetes, pregnancy, poor
socioeconomic status, and smoking are recognized risk
factors.
The patient presented herein had not been circum-
cised (Figure 1) and was also immunosuppressed, with a
low CD4 count, despite having been on ARVs for a long
period. Although immunosuppression is a recognized
risk factor, giant condyloma acuminatum in the back-
ground of HIV/AIDS and ARV therapy is extremely rare
and poses difficulties in decision making. How radical
should surgical extirpation be? How aggressive should
any adjuvant therapy be? The use of ARVs and immu-
nosuppressants and/or immunomodulators is established
in the care of renal transplant patients with HIV infec-
tion. A meta-analysis by Landin et al. of 12 series of
reports of HIV-positive recipients under HAART receiv-
ing kidney transplants [7] reported the development of
an AIDS-defining tumor in a single patient. A conclu-
sion of this meta-analysis was that renal transplantation,
and therefore the use of immunosuppressive therapy, is
Figure 1 Giant condyloma acuminatum of the scrotum. Note multiple ulcers and discharging sinuses on the scrotum, thigh, and suprapubic
areas.
Nthumba et al. Journal of Medical Case Reports 2011, 5:272
http://www.jmedicalcasereports.com/content/5/1/272
Page 2 of 5safe in patients with HIV undergoing highly active anti-
retroviral therapy (HAART). There have been no reports
on the use of immunosuppressive therapy in patients
with AIDS who are being treated with ARVs, however.
The rarity of giant condyloma acuminatum in patients
with HIV/AIDS is puzzling, considering that HPV is
known to be the underlying cause of this lesion and also
underlies cervical cancer, an AIDS-defining cancer, and
anal cancer, a non-AIDS-defining cancer. The incidence
of these lesions has not been affected by the use of
ARVs. A possible explanation may be that HAART has
largely eliminated giant condyloma acuminatum, a clini-
cally benign tumor. This is conceivable, given the biolo-
gical differences between giant condyloma acuminatum
and squamous cell carcinoma. Under-reporting of cases
of giant condyloma acuminatum with underlying HIV/
AIDS is the other possible explanation for the paucity of
literature on this rare condition.
Wide surgical excision, radiochemotherapy, topical
and intra-lesional chemotherapy, carbon dioxide laser
therapy, and photodynamic therapy have all been used
in different combinations in the treatment of giant con-
dyloma acuminatum, with varying success. Tytherleigh
et al. [8] reported the successful use of neo-adjuvant
chemoradiotherapy to down-size a tumor with subse-
quent complete surgical excision. The administration of
an autogenous vaccine after surgical excision has the
lowest reported recurrence rates at one year (less than
5%) [9]. There is a risk of transformation of a giant con-
dyloma acuminatum into an aggressive squamous cell
carcinoma (30% to 56% over five years), in addition to a
10% risk of anaplastic transformation after radiotherapy
[1,6].
Surgery remains the most effective mode of manage-
ment. In our patient, wide excision of the tumor was
performed, but the deep perineal margins were difficult
to obtain as this would have required a total penectomy,
bilateral pubectomy, and resection of the pelvic dia-
phragm, an extensive procedure with significant morbid-
ity that was considered unwarranted in a patient in
whom the primary goal was palliation, considering his
diagnosis of AIDS. Total penectomy and perineal ure-
throstomy have been reported previously [3].
Post-operatively, our patient was able to ambulate and
perform a number of activities of daily living; the foul-
smelling exudate and pain were gone. Upon discharge,
his ability to feed, wash, clean himself after a bowel
movement, and dress himself were very rewarding.
Surgical excision is the primary mode of treatment of
giant condyloma acuminatum. Recurrence rates of 50%
have been reported [1]. Tumor recurrence in our
patient was noted six months post-operatively. The
patient’s improved nutritional status and motivation
may warrant a revision of the original intent of the
surgery, subject to the patient’s consent, allowing an
aggressive surgical excision. There is as yet no evi-
dence of the efficacy of immunosuppressive therapy
administered to patients with AIDS receiving ARV
therapy. Certainly the challenges presented by emer-
ging or unusual presentations of surgical pathology
secondary to HIV/AIDS offer a challenge and indicate
the need to establish guidelines on the use of
Figure 2 Post-resection extent into both thighs and deep margins defined by the rectus sheath superiorly and the pubic arches and
symphysis. The proximal penile shaft and both testicles are completely exposed.
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patient population [10,11].
The patient reported herein recovered well after exten-
sive surgery, despite his compromised immune status in
an environment with limited resources. The case repre-
sents a challenge in clinical decision making when faced
by scenarios such as we did in this case: conservative pal-
liation (which would have condemned our patient to
continued suffering) versus surgical palliation (which
offered the opportunity for an improved quality of life
but placed the patient and caregivers at potential risk).
Conclusion
Giant condyloma acuminatum, rarely reported in
patients with HIV/AIDS, is a rare, locally aggressive
tumor that may recur early after surgical excision.
Figure 3 Six weeks post-resection pedicled anterolateral thigh flap reconstruction of scrotum and perineum is shown.
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vention is complex and involves palliative excision ver-
sus a curative excision that has the potential for
significant morbidity in a patient who is terminally ill.
Wide surgical excision with local flap reconstruction sig-
nificantly improved the quality of life of the patient pre-
sented here.
The challenges of treating patients with emerging or
unusual presentations of surgical pathology secondary to
HIV/AIDS who are receiving ARV therapy provide the
opportunity for research and the establishment of guide-
lines on the use of adjuvant chemotherapy.
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